Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 153

PubMed (GeneRIF) for Gene (Select 2903)

1.

GRIN2A: an aptly named gene for speech dysfunction.

Turner SJ, Mayes AK, Verhoeven A, Mandelstam SA, Morgan AT, Scheffer IE.

Neurology. 2015 Feb 10;84(6):586-93. doi: 10.1212/WNL.0000000000001228. Epub 2015 Jan 16.

PMID:
25596506
2.

Caffeine interaction with glutamate receptor gene GRIN2A: Parkinson's disease in Swedish population.

Yamada-Fowler N, Fredrikson M, Söderkvist P.

PLoS One. 2014 Jun 10;9(6):e99294. doi: 10.1371/journal.pone.0099294. eCollection 2014.

3.

HIV-1 Tat-mediated apoptosis in human blood-retinal barrier-associated cells.

Che X, He F, Deng Y, Xu S, Fan X, Gu P, Wang Z.

PLoS One. 2014 Apr 16;9(4):e95420. doi: 10.1371/journal.pone.0095420. eCollection 2014.

4.

Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation.

Prickett TD, Zerlanko BJ, Hill VK, Gartner JJ, Qutob N, Jiang J, Simaan M, Wunderlich J, Gutkind JS, Rosenberg SA, Samuels Y.

J Invest Dermatol. 2014 Sep;134(9):2390-8. doi: 10.1038/jid.2014.190. Epub 2014 Apr 16.

5.

A subset of genomic alterations detected in rolandic epilepsies contains candidate or known epilepsy genes including GRIN2A and PRRT2.

Dimassi S, Labalme A, Lesca G, Rudolf G, Bruneau N, Hirsch E, Arzimanoglou A, Motte J, de Saint Martin A, Boutry-Kryza N, Cloarec R, Benitto A, Ameil A, Edery P, Ryvlin P, De Bellescize J, Szepetowski P, Sanlaville D.

Epilepsia. 2014 Feb;55(2):370-8. doi: 10.1111/epi.12502. Epub 2013 Dec 24.

PMID:
24372385
6.

The σ-1 receptor interacts directly with GluN1 but not GluN2A in the GluN1/GluN2A NMDA receptor.

Balasuriya D, Stewart AP, Edwardson JM.

J Neurosci. 2013 Nov 13;33(46):18219-24. doi: 10.1523/JNEUROSCI.3360-13.2013.

7.

Human immunodeficiency virus-1 Tat protein increases the number of inhibitory synapses between hippocampal neurons in culture.

Hargus NJ, Thayer SA.

J Neurosci. 2013 Nov 6;33(45):17908-20. doi: 10.1523/JNEUROSCI.1312-13.2013.

8.

Pathological reorganization of NMDA receptors subunits and postsynaptic protein PSD-95 distribution in Alzheimer's disease.

Leuba G, Vernay A, Kraftsik R, Tardif E, Riederer BM, Savioz A.

Curr Alzheimer Res. 2014 Jan;11(1):86-96.

PMID:
24156266
9.

Two patients with a GRIN2A mutation and childhood-onset epilepsy.

DeVries SP, Patel AD.

Pediatr Neurol. 2013 Dec;49(6):482-5. doi: 10.1016/j.pediatrneurol.2013.08.023. Epub 2013 Oct 11.

PMID:
24125812
10.

Chemokine co-receptor CCR5/CXCR4-dependent modulation of Kv2.1 channel confers acute neuroprotection to HIV-1 glycoprotein gp120 exposure.

Shepherd AJ, Loo L, Mohapatra DP.

PLoS One. 2013 Sep 24;8(9):e76698. doi: 10.1371/journal.pone.0076698. eCollection 2013.

11.

Analysis of variations in the glutamate receptor, N-methyl D-aspartate 2A (GRIN2A) gene reveals their relative importance as genetic susceptibility factors for heroin addiction.

Zhao B, Zhu Y, Wang W, Cui HM, Wang YP, Lai JH.

PLoS One. 2013 Aug 5;8(8):e70817. doi: 10.1371/journal.pone.0070817. Print 2013.

12.

Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes.

Lemke JR, Lal D, Reinthaler EM, Steiner I, Nothnagel M, Alber M, Geider K, Laube B, Schwake M, Finsterwalder K, Franke A, Schilhabel M, Jähn JA, Muhle H, Boor R, Van Paesschen W, Caraballo R, Fejerman N, Weckhuysen S, De Jonghe P, Larsen J, Møller RS, Hjalgrim H, Addis L, Tang S, Hughes E, Pal DK, Veri K, Vaher U, Talvik T, Dimova P, Guerrero López R, Serratosa JM, Linnankivi T, Lehesjoki AE, Ruf S, Wolff M, Buerki S, Wohlrab G, Kroell J, Datta AN, Fiedler B, Kurlemann G, Kluger G, Hahn A, Haberlandt DE, Kutzer C, Sperner J, Becker F, Weber YG, Feucht M, Steinböck H, Neophythou B, Ronen GM, Gruber-Sedlmayr U, Geldner J, Harvey RJ, Hoffmann P, Herms S, Altmüller J, Toliat MR, Thiele H, Nürnberg P, Wilhelm C, Stephani U, Helbig I, Lerche H, Zimprich F, Neubauer BA, Biskup S, von Spiczak S.

Nat Genet. 2013 Sep;45(9):1067-72. doi: 10.1038/ng.2728. Epub 2013 Aug 11.

PMID:
23933819
13.

GRIN2A mutations cause epilepsy-aphasia spectrum disorders.

Carvill GL, Regan BM, Yendle SC, O'Roak BJ, Lozovaya N, Bruneau N, Burnashev N, Khan A, Cook J, Geraghty E, Sadleir LG, Turner SJ, Tsai MH, Webster R, Ouvrier R, Damiano JA, Berkovic SF, Shendure J, Hildebrand MS, Szepetowski P, Scheffer IE, Mefford HC.

Nat Genet. 2013 Sep;45(9):1073-6. doi: 10.1038/ng.2727. Epub 2013 Aug 11.

14.

A novel alcohol-sensitive position in the N-methyl-D-aspartate receptor GluN2A subunit M3 domain regulates agonist affinity and ion channel gating.

Ren H, Zhao Y, Wu M, Peoples RW.

Mol Pharmacol. 2013 Oct;84(4):501-10. doi: 10.1124/mol.113.085993. Epub 2013 Jul 11.

15.

A risk variant for alcoholism in the NMDA receptor affects amygdala activity during fear conditioning in humans.

Cacciaglia R, Nees F, Pohlack ST, Ruttorf M, Winkelmann T, Witt SH, Nieratschker V, Rietschel M, Flor H.

Biol Psychol. 2013 Sep;94(1):74-81. doi: 10.1016/j.biopsycho.2013.05.006. Epub 2013 May 18.

PMID:
23693003
16.

A role for spermine oxidase as a mediator of reactive oxygen species production in HIV-Tat-induced neuronal toxicity.

Capone C, Cervelli M, Angelucci E, Colasanti M, Macone A, Mariottini P, Persichini T.

Free Radic Biol Med. 2013 Oct;63:99-107. doi: 10.1016/j.freeradbiomed.2013.05.007. Epub 2013 May 9.

PMID:
23665428
17.

Nedd4 is a specific E3 ubiquitin ligase for the NMDA receptor subunit GluN2D.

Gautam V, Trinidad JC, Rimerman RA, Costa BM, Burlingame AL, Monaghan DT.

Neuropharmacology. 2013 Nov;74:96-107. doi: 10.1016/j.neuropharm.2013.04.035. Epub 2013 Apr 29.

18.

Inhibition of N-methyl-D-aspartate-activated current by bis(7)-tacrine in HEK-293 cells expressing NR1/NR2A or NR1/NR2B receptors.

Liu Y, Li C.

J Huazhong Univ Sci Technolog Med Sci. 2012 Dec;32(6):793-7. doi: 10.1007/s11596-012-1036-0. Epub 2012 Dec 28.

PMID:
23271275
19.

Human immunodeficiency virus-1 protein Tat induces excitotoxic loss of presynaptic terminals in hippocampal cultures.

Shin AH, Thayer SA.

Mol Cell Neurosci. 2013 May;54:22-9. doi: 10.1016/j.mcn.2012.12.005. Epub 2012 Dec 23.

20.

HIV immune complexes prevent excitotoxicity by interaction with NMDA receptors.

Rumbaugh JA, Bachani M, Li W, Butler TR, Smith KJ, Bianchet MA, Wang T, Prendergast MA, Sacktor N, Nath A.

Neurobiol Dis. 2013 Jan;49:169-76. doi: 10.1016/j.nbd.2012.08.013. Epub 2012 Aug 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk